2022
DOI: 10.3390/molecules27144632
|View full text |Cite
|
Sign up to set email alerts
|

Maleimide-Functionalized Liposomes: Prolonged Retention and Enhanced Efficacy of Doxorubicin in Breast Cancer with Low Systemic Toxicity

Abstract: Cell surface thiols can be targeted by thiol-reactive groups of various materials such as peptides, nanoparticles, and polymers. Here, we used the maleimide group, which can rapidly and covalently conjugate with thiol groups, to prepare surface-modified liposomes (M-Lip) that prolong retention of doxorubicin (Dox) at tumor sites, enhancing its efficacy. Surface modification with the maleimide moiety had no effect on the drug loading efficiency or drug release properties. Compared to unmodified Lip/Dox, M-Lip/D… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 6 publications
(3 citation statements)
references
References 32 publications
(32 reference statements)
0
3
0
Order By: Relevance
“…For instance, betulinic acid can be utilized for treatment of colorectal cancer, but when it is loaded in pH-sensitive liposomal nanoparticles prepared from Eudragit S100, its cytotoxicity against tumor cells enhances and based on in vitro and in vivo studies, these drug-loaded liposomes are able to decrease expression levels of NFAT1 and NFAT4, and enhance natural killer (NK) and CD3+ cells in improving anti-tumor immunity against colorectal tumor [50] . The previous study focused on delivery of a naturally occurring anti-tumor compound in cancer therapy and notably, chemotherapy agents such as DOX can be delivered by liposomes in cancer therapy [51] . DOX is an inhibitor of topoisomerase II and due to high cases of chemoresistance, its delivery by nanostructures has been of importance .…”
Section: Liposomes In Cancer Therapy: a Summarymentioning
confidence: 99%
See 1 more Smart Citation
“…For instance, betulinic acid can be utilized for treatment of colorectal cancer, but when it is loaded in pH-sensitive liposomal nanoparticles prepared from Eudragit S100, its cytotoxicity against tumor cells enhances and based on in vitro and in vivo studies, these drug-loaded liposomes are able to decrease expression levels of NFAT1 and NFAT4, and enhance natural killer (NK) and CD3+ cells in improving anti-tumor immunity against colorectal tumor [50] . The previous study focused on delivery of a naturally occurring anti-tumor compound in cancer therapy and notably, chemotherapy agents such as DOX can be delivered by liposomes in cancer therapy [51] . DOX is an inhibitor of topoisomerase II and due to high cases of chemoresistance, its delivery by nanostructures has been of importance .…”
Section: Liposomes In Cancer Therapy: a Summarymentioning
confidence: 99%
“…DOX is an inhibitor of topoisomerase II and due to high cases of chemoresistance, its delivery by nanostructures has been of importance . Application of liposomes functionalized with maleimide is beneficial for promoting retention of DOX at tumor site and enhances its cytotoxicity against breast tumor cells [51] . The more interesting part related to liposomes is their ability in delivery of two anti-tumor compounds.…”
Section: Liposomes In Cancer Therapy: a Summarymentioning
confidence: 99%
“…For example, coating liposomes with chitosan increased the mucoadhesion of the liposomes and resulted in an increased AUC plasma of sumatriptan [ 115 ]. Maleimide has been used in many studies to develop mucoadhesive liposomes due to its interactions with the sulfhydryl groups in mucins [ 116 , 117 ]. This polymer can be used for functionalizing IN liposomes with mucoadhesive characteristics in future studies.…”
Section: Intranasal Liposomes For Systemic and Brain Delivery Of Drug...mentioning
confidence: 99%